Has Julia Hudson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,990 in general payments to Julia Hudson, MD across 35 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Julia Hudson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Julia Hudson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Julia Hudson, MD

Retina Specialist · Carmel, INNPI 1265937676

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,330 of the $2,990 with a category attached, or 77.9%. Alcon accounts for 64.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $1,066 and has fallen 93.2% since, to $72 in 2025.

$2,990in general payments, 2019–2025

Across 35 payments — averaging $85.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$2K
AbbVie$184
Sight Sciences, Inc.$141
Regeneron Healthcare Solutions, Inc.$139
Astellas Pharma US Inc$132
Bausch & Lomb Americas Inc.$124
plus $343 from 6 others

What the payments were for

Travel & lodging$66122%
Food & beverage$2,33078%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	19	$1,927
AbbVie(2 entities)	2	$184
Sight Sciences, Inc.	1	$141
Regeneron Healthcare Solutions, Inc.	2	$139
Astellas Pharma US Inc	2	$132
Bausch & Lomb Americas Inc.	2	$124
Amgen	1	$116
Mallinckrodt Enterprises LLC	1	$114
Genentech USA, Inc.	2	$57
NEW World Medical,inc.	1	$23
Rayner Intraocular Lenses Limited	1	$17
Ocular Therapeutix, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,990 in reported general payments places this provider in the 60th percentile of 21 retina specialist providers in Indiana.

See all retina specialist providers in Indiana →

Medicare billing

Part B allowed, 2024

$152,592

Medicare patients

253

Services billed

935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	102	$3,901
Difluprednate	14	$1,909
Brimonidine Tartrate	79	$1,491
MoxifloxacinMoxifloxacin Hcl	50	$1,402
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	64	$764
ValacyclovirValacyclovir Hcl	13	$672
Atropine Sulfate	21	$654
Latanoprost	61	$393
Ketorolac Tromethamine	23	$291
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	23	$270
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim	30	$246
ErythromycinErythromycin Base	14	$142
Timolol Maleate	13	$124

Paid to pharmacies, not to this prescriber.

Other retina specialist in Carmel

Ankur ShahCarmel$569K
Raj MaturiCarmel$100K
Ramana MoorthyCarmel$61K
Milan ShahCarmel$35K
Rodney BucherCarmel$30K
Stephen SaxeCarmel$610
Frederick PrallCarmel$475
Mark KaehrCarmel$451
John MinturnCarmel$133
Denis JusufbegovicCarmel$123

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →